A controlled phage therapy can target drug-resistant bacteria while sidestepping potential unintended consequences

The fight against drug-resistant pathogens remains an intense one. While the Centers for Disease Control's (CDC) 2019 'biggest threats' report reveals an overall decrease in drug-resistant microbe-related deaths as compared to its previous report (2013) the agency also cautions that new forms of drug-resistant pathogens are still emerging.